CooperCompanies Launches Strategic Review and Names New Board Chair
CooperCompanies initiates strategic review exploring partnerships and divestitures while appointing Colleen Jay as new board chair. Q4 revenue up 5% to $1.07B.
Feed↓
/ What's going on?
Filter:
Praxis Precision Medicines Achieves Key Milestones in Neurological Treatments
Praxis Precision Medicines announces FDA alignment for essential tremor drug and positive results for epilepsy treatment, marking major progress in neurological disorder therapies.
FDA Clears Vanda's Tradipitant for Motion Sickness Studies
The FDA has lifted a study restriction on Vanda Pharmaceuticals' Tradipitant, potentially making it the first new motion sickness drug in decades.
HPE Stock Drops on Weak Q1 Forecast Amid AI Project Delays
Hewlett Packard Enterprise shares fall as Q1 revenue outlook misses estimates due to delayed AI deals and cautious enterprise spending amid economic uncertainty.
Rubrik Crushes Q3 Expectations, Raises Full-Year Outlook
Rubrik (RBRK) reports strong Q3 results with $0.10 EPS beating estimates by $0.27. Revenue hits $350.2M as cybersecurity firm raises FY2026 guidance above consensus.
US Senators Introduce Bill to Block Nvidia Chips Sales to China
A new bipartisan bill would block Nvidia from selling its most advanced AI chips to China for 30 months, aiming to maintain the US lead in artificial intelligence.